Joint investment to accelerate UK sustainable biomanufacturing
European Pharmaceutical Review
MARCH 1, 2024
UKRI highlighted that overall, these investments will “enhance the UK’s global competitiveness by supporting research and innovation that leads to new and disruptive biomanufacturing processes across the UK.” Curious about sustainability in pharmaceutical manufacturing and the supply chain?
Let's personalize your content